×
Onclive On Air public
[search 0]
×
Best Onclive On Air podcasts we could find (updated December 2019)
Best Onclive On Air podcasts we could find
Updated December 2019
Join millions of Player FM users today to get news and insights whenever you like, even when you're offline. Podcast smarter with the free podcast app that refuses to compromise. Let's play!
Join the world's best podcast app to manage your favorite shows online and play them offline on our Android and iOS apps. It's free and easy!
More
show episodes
 
O
OncLive® On Air
Weekly
 
In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.
 
Loading …
show series
 
We recently traveled to Chicago, Illinois for a State of the Science Summit™ on Lung Cancer. At the meeting, faculty from the University of Chicago emphasized the impact of immunotherapy in non–small cell lung cancer, including the paradigm shift in the treatment of patients with stage III disease, promising combinations under exploration in st ...…
 
In our exclusive interview, Dr. Tanios Bekaii-Saab spent time discussing the path to practicing in gastrointestinal malignancies, how he navigates balancing his professional and personal life, and mottos he has lived by throughout his career and while caring for his patients.By OncLive® On Air
 
We recently traveled to Raleigh-Durham, North Carolina for a State of the Science Summit™ on Breast Cancer. At the meeting, faculty from Duke Cancer Institute explained how prognostic and predictive assays are being used to guide treatment decisions in breast cancer, provided perspective on the optimal use of HER2-targeted therapy, antibody-dru ...…
 
We recently traveled to New York City, New York, for a State of the Science Summit™ on Multiple Myeloma. Although the treatment paradigm in multiple myeloma is guided by transplant eligibility, and grounded in the use of immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, certain elements of practice are not as well descri ...…
 
We recently traveled to Salt Lake City, Utah for a State of the Science Summit™ on Non–Small Cell Lung Cancer. At the meeting, faculty from the University of Utah and Intermountain Healthcare, delved into biomarker discoveries, research regarding the heredity of lung cancer, emerging treatment modalities, and practice-changing trials that have ...…
 
Howard A. Burris, MD, also known as Skip, of Sarah Cannon Research Institute, discussed how he wound up in the oncology space, his passion for getting to know and helping his patients, and some proud moments throughout his monumental career.By OncLive® On Air
 
We recently traveled to Pittsburgh, Pennsylvania for a State of the Science Summit™ on Ovarian Cancer. At the meeting, faculty from the University of Pittsburgh Medical Center highlighted the many advances made with PARP inhibitors, the importance of molecular testing, considerations for the frontline treatment of newly diagnosed disease, as we ...…
 
Jane L. Meisel, MD, and Aditya Bardia, MD, MPH, shed light on treatment considerations for women with triple-negative breast cancer (TNBC) who are candidates for neoadjuvant therapy, emerging treatment strategies for patients with metastatic TNBC, as well as the optimal timing of genomic testing in women with progressive hormone receptor–positi ...…
 
We recently traveled to Seattle, California for a State of the Science Summit™ on Hematologic Malignancies. At the meeting, faculty from Seattle Cancer Care Alliance provided insight on current and evolving standards of care in leukemia, lymphoma, and myeloma, highlighting particular targets of interest for novel therapies.…
 
We recently traveled to Milwaukee, Wisconsin, for a State of the Science Summit™ on Breast Cancer. At the meeting, faculty from Carbone Cancer Center of the University of Wisconsin highlighted the evolving paradigms across breast cancer subtypes and settings, such as early and advanced hormone receptor–positive breast cancer, early-stage HER2-p ...…
 
We recently traveled to Pasadena, California, for a State of the Science Summit™ on Ovarian Cancer. At the meeting, faculty from City of Hope discussed the necessity of genetic testing as well as the latest data regarding the use of PARP inhibitors, immunotherapy, chemotherapy, and surgical debulking while explaining how these data can be inter ...…
 
Maha Hussain, MD, FACP, FASCO, of Northwestern University Feinberg School of Medicine, reflected on the path that led her into genitourinary cancers.By OncLive® On Air
 
We recently traveled to Denver, Colorado, for a State of the Science Summit on Gastrointestinal Malignancies, which featured insights from University of Colorado and Rocky Mountain Cancer Centers faculty. Meeting topics spanned the importance of molecular testing in the management of newly diagnosed metastatic colorectal cancer, advances with b ...…
 
We recently traveled to New York City, New York, for a State of the Science Summit on Multiple Myeloma. We met with experts from Mount Sinai Hospital to gather updates on emerging treatment strategies in multiple myeloma, including headway made with CAR T-cell therapies, the role of genomics, the shift toward personalized medicine, and progress ...…
 
We recently traveled to Boston, Massachusetts, for a State of the Science Summit™ on Genitourinary Cancers. At the meeting, experts from Dana-Farber Cancer Institute discussed the latest updates in prostate cancer, including the role of radiation, the question of androgen deprivation therapy–associated cardiac complications, and novel imaging m ...…
 
We recently traveled to Milwaukee, Wisconsin for a State of the Science Summit™ on Hematologic Malignancies. We met with experts from the Medical College of Wisconsin to gather updates in acute myeloid leukemia, multiple myeloma, chronic lymphocytic leukemia, mantle cell lymphoma, and myeloproliferative neoplasms. Additionally, we heard the lat ...…
 
We recently traveled to Little Rock, Arkansas, for a State of the Science Summit™ on Non–Small Cell Lung Cancer. In advance of the meeting, we conducted a Twitter poll regarding the use of single-agent immunotherapy versus combination chemotherapy and immunotherapy in a patient with nonsquamous non–small cell lung cancer. During the meeting, we ...…
 
We recently traveled to Lexington, Kentucky for a State of the Science Summit on Neuroendocrine Tumors. The meeting, led by experts from University of Kentucky Markey Cancer Center, spotlighted the latest management strategies in the treatment of patients with neuroendocrine tumors, starting with the diagnosis, classification, and staging of th ...…
 
We recently traveled to Pasadena, California, for a State of the Science Summit on Breast Cancer. The meeting, which featured insight from experts from City of Hope, covered a wide array of topics, ranging from advances made in HER2-positive breast cancer, to key trials in metastatic triple-negative disease, to genomic assays used in hormone re ...…
 
Patrick I. Borgen, MD, of Maimonides Medical Center, shares his live-by mottos as a breast cancer surgeon, a patient who defined his career, and what fuels his passion to fight breast cancer and remove opioid use after surgery.By OncLive® On Air
 
We recently traveled to Dallas, Texas for a State of the Science Summit on Non–Small Cell Lung Cancer. At the meeting, faculty from Baylor Scott and White Health System highlighted headway made in the treatment landscapes of non–small cell lung cancer according to histology, stage, and treatment intervention, the likes of which now include immu ...…
 
We recently traveled to Tampa, Florida, for a State of the Science Summit on Gastrointestinal Malignancies. At the meeting, faculty from Moffitt Cancer Center and Mayo Clinic reviewed the latest data in gastrointestinal oncology, covering all aspects of current care, from patient selection to the optimal timing of targeted therapy, immunotherap ...…
 
We recently traveled to Boston, Massachusetts, for a State of the Science Summit on Hematologic Malignancies, which featured insights from the faculty from Dana-Farber Cancer Institute. The meeting covered frontline approaches and sequencing challenges in multiple myeloma, key advances in mantle cell lymphoma, and novel agents in chronic lympho ...…
 
We recently traveled to Dallas, Texas, for a State of the Science Summit on Breast Cancer. During the meeting, faculty from Baylor Scott and White Health System and The University of Texas MD Anderson Cancer Center relayed the prognostic value of genomic assays in breast cancer and the scope of established and ensuing treatment approaches for t ...…
 
We recently traveled to Charlotte, North Carolina, for a State of the Science Summit™ on Gastrointestinal Cancers. During the meeting, the faculty shared expert insight on treatment approaches across metastatic colorectal cancer, locally advanced and metastatic pancreatic cancer, advanced hepatocellular carcinoma, neuroendocrine tumors, and adv ...…
 
We recently traveled to New York City, New York, for a State of the Science SummitTM on Ovarian Cancer.By OncLive® On Air
 
We recently traveled to Durham, North Carolina, for a State of the Science Summit™ on Gastrointestinal Malignancies. At the meeting, we spoke with the faculty from Duke Health and UNC Health Care, who highlighted key updates from the 2019 Gastrointestinal Symposium. Key topics included the importance of molecular profiling in colorectal cancer, ...…
 
We recently traveled to Chicago, Illinois, for a State of the Science Summit™ on Breast Cancer. During the meeting, the faculty provided a comprehensive look into present and potentially future standards of care in early-stage and advanced breast cancer subtypes.By OncLive® On Air
 
We recently traveled to Washington D.C. for a State of the Science Summit on Gastrointestinal Malignancies. During the meeting, the faculty spoke to the clinically diverse and steadily expanding therapeutic armamentariums for patients with gastrointestinal malignancies.By OncLive® On Air
 
We recently traveled to Kansas City, Missouri, for a State of the Science Summit™ on Hematologic Malignancies. The meeting provided a comprehensive snapshot of the pivotal data that were presented at the 2018 ASH Annual Meeting, spanning several diseases, such as multiple myeloma, chronic lymphocytic leukemia, acute myeloid leukemia, and much more.…
 
We recently traveled to New York City for a State of the Science SummitTM on Ovarian Cancer and Soft Tissue Sarcoma. In keeping up with the constant and sometimes controversial landscape of ovarian cancer, we sat down with Mario M. Leitao Jr, MD, FACOG, FACS, and Dmitriy Zamarin, MD, PhD, of Memorial Sloan Kettering Cancer Center, to discuss tw ...…
 
Recently, we traveled to Houston, Texas, for a State of the Science Summit™ on Gastrointestinal Malignancies. At the meeting, faculty from the University of Texas MD Anderson Cancer Center and Baylor College of Medicine, discussed the rapidly evolving landscapes of colorectal cancer, gastric/GEJ cancer, pancreatic cancer, neuroendocrine tumors, ...…
 
We recently ventured to Nashville, Tennessee for a State of the Science SummitTM on Breast Cancer. At this conference, we sat down with faculty from Sarah Cannon Research Institute, HCA Midwest Health, Virginia Cancer Specialists, and Memorial Sloan Kettering Cancer Center to discuss some of the practice-changing updates that have been occurrin ...…
 
We recently traveled to Pasadena, California for a State of the Science Summit™ on Gastrointestinal Malignancies. In keeping up with the rapidly changing landscape of gastroesophageal junction cancer, we sat down with Joseph Chao, MD, to discuss a clinical scenario he faced in practice, and how he used the latest data available to inform his tr ...…
 
We recently traveled to Pasadena, California, for a State of the Science Summit™ on Genitourinary Malignancies. At the meeting, faculty from City of Hope, Huntsman Cancer Center, and the University of Washington discussed the rapidly evolving landscapes of kidney, bladder, and prostate cancer.By OncLive® On Air
 
We recently traveled to New York City for a State of the Science Summit™ on Breast Cancer. During the meeting, faculty from the Icahn School of Medicine of Mount Sinai Health System, as well as Columbia University Medical Center, discussed the latest updates in the rapidly evolving paradigms of triple-negative breast cancer, HER2-positive breas ...…
 
We sat down with Marwan Fakih, MD, to discuss a clinical scenario he faced in practice, and how he used the latest data available to inform his treatment for his patient.By OncLive® On Air
 
We recently traveled to Boston, Massachusetts, for a State of the Science Summit™ on Ovarian Cancer and Soft Tissue Sarcoma. During the meeting, faculty from Dana-Farber Cancer Institute gave focused presentations on the facets of genetic testing in ovarian cancer, surgical options available for patients with newly diagnosed disease, and emergi ...…
 
We recently traveled to Kansas City, Missouri, for a State of the Science Summit™ on Advanced Non–Small Cell Lung Cancer. During the meeting, the faculty from St. Luke’s Cancer Institute and the University of Missouri-Kansas City gave focused presentations on recent progress made in squamous NSCLC and small cell lung cancer, provided tips on ho ...…
 
We recently traveled to Memphis, Tennessee, for a State of the Science Summit™ on Genitourinary Cancers. During the meeting, the faculty gave focused presentations on advances made in the treatment landscapes of metastatic renal cell carcinoma and prostate cancer. In renal cell carcinoma, the faculty homed in on the role of adjuvant TKIs, the c ...…
 
We recently traveled to New York City for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer. The meeting, which featured insight from experts from NYU Langone’s Perlmutter Cancer Center, covered a wide array of topics, ranging from surgical techniques, to headway made in immunotherapy, to emerging biomarkers, to diagnostic ad ...…
 
We recently traveled to Minneapolis, Minnesota, for a State of the Science Summit on Breast Cancer. At the meeting, topics ranged from surgical approaches for node-positive breast cancer, to the use of CDK4/6 inhibitors in hormone receptor–positive disease, to emerging drug therapies in triple-negative disease. Presenters also highlighted treat ...…
 
We recently traveled to Syracuse, New York, for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer. At the meeting, we spoke with the faculty of Upstate Medical University on practice-change clinical trials in the space, as well as novel approaches to treatment with checkpoint inhibitors, targeted therapies, radiation, and min ...…
 
We recently traveled to New York City for a State of the Science Summit on Multiple Myeloma. At the meeting, we spoke with the faculty of Mount Sinai to get their take on stem cell transplant, minimal residual disease, maintenance options, and treatment approaches for newly diagnosed myeloma. They also discussed outcomes for relapsed/refractory ...…
 
Recently, we headed to Washington D.C. for a State of the Science Summit on Non–Small Cell Lung Cancer. Topics ranged from determining optimal strategies for molecular interrogation in NSCLC to the emergence of rare, targetable biomarkers—such as MET, RET, and NTRK. Presentations also focused on additional recent advances in the NSCLC and small ...…
 
Recently, we visited Pittsburgh, Pennsylvania for a State of the Science Summit on Breast Cancer. Topics of discussion ranged from controversies in the management of hormone receptor-positive breast cancer to de-escalating therapy for patients with HER2-positive disease. Presentations also focused on novel approaches in metastatic triple-negati ...…
 
In December 2018, we traveled to San Diego, California for the 2018 ASH Annual Meeting. At the conference, we spoke with several experts across hematologic malignancies, including mantle cell lymphoma, chronic lymphocytic leukemia, and multiple myeloma.By OncLive® On Air
 
We visited San Antonio, Texas for the San Antonio Breast Cancer Symposium. At the meeting, physicians from all around the world presented studies in the field, several of which will have an immediate impact on practice. During our time there, we spoke to several principal investigators who detailed new applications of novel therapies, surgical ...…
 
We visited Stanford, California for a State of the Science Summit on Ovarian Cancer and Soft Tissue Sarcoma. The meeting covered advances made in the treatment landscapes, touching on available modalities, such as immunotherapy, antibody drug conjugates, and PARP inhibitors.By OncLive® On Air
 
On October 23, we traveled to Chicago, Illinois, for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer. At the meeting, faculty from Rush University Medical Center, the University of Chicago Medicine, the University of Illinois at Chicago, NorthShore University Health System, and Northwestern Feinberg School of Medicine refle ...…
 
Google login Twitter login Classic login